Skip to Content
Sara Best, MD

Contact Dr. Best

E-mail:
best@urology.wisc.edu

Phone:
(608) 263-9534

Mail:
UW Medical Foundation Centennial Building
1685 HIGHLAND AVE
MADISON, WI 53705-2281

Sara Best, MD

Assistant Professor (CHS)

Education

  • MD, University of Wisconsin Medical School, Madison, Wisconsin, 2003
  • Endourology Research Fellowship, University of Minnesota, 2004
  • Residency, University of Wisconsin, Madison, Wisconsin, 2009
  • Endourology and Minimally Invasive Urology Fellowship, University of Texas Southwestern, Dallas, Texas, 2011

Clinical Specialties

Dr. Best is certified by the American Board of Urology and specializes in minimally invasive surgical treatment of urologic cancers and stone disease. She has advanced training in laparoscopic and robotic surgery for kidney cancer, prostate cancer, and kidney/ureter reconstruction. She also manages patients with kidney stones, including the full range of surgical therapies and medical management. She has a special interest in performing robotic partial nephrectomies for kidney cancer. Her philosophy is to try to get patients back to their “normal lives” as quickly as possible by using minimally invasive approaches whenever possible.

Research Interests

Dr. Best’s research interests lie in the study of kidney cancer and disease using optics, the development of new technology for minimally invasive surgery, and urinary stone disease.

Recent Publications
  • Best SL. Erastus B. Wolcott: A Pioneer in Renal Surgery and Frontier Medicine. Urology 2016 May 16.
    [PubMed ID: 27196031]
    More Information
  • Streeper NM, Nakada SY, Wertheim ML, Best SL. Preliminary Evidence Suggests Periureteral Botulinum Toxin Type A Injection Improves Ureteral Stone Passage in the Porcine Model. J. Endourol. 2016 Mar; 30(3):327-31.
    [PubMed ID: 26560963]
    More Information
  • Blute ML, Zorn K, Grimes M, Shi F, Downs TM, Jarrard DF, Best SL, Richards K, Nakada SY, Abel EJ. Extreme Obesity Does Not Predict Poor Cancer Outcomes Following Surgery for Renal Cell Cancer. BJU Int. 2015 Nov 21.
    [PubMed ID: 26589741]
    More Information
  • Sivalingam S, Streeper NM, Sehgal PD, Sninsky BC, Best SL, Nakada SY. Does Combination Therapy with Tamsulosin and Tolterodine Improve Ureteral Stent Discomfort Compared with Tamsulosin Alone? A Double-Blind, Randomized, Controlled Trial. J. Urol. 2016 Feb; 195(2):385-90.
    [PubMed ID: 26393904]
    More Information
  • Best SL, Sivalingam S, Penniston KL, Nakada SY. Radiographic and laboratory data ("the Megaprofile") can accurately guide medical management in the absence of stone analysis. J. Endourol. 2015 Mar; 29(3):357-61.
    [PubMed ID: 25025627]
    More Information
  • Moreland AJ, Ziemlewicz TJ, Best SL, Hinshaw JL, Lubner MG, Alexander ML, Brace CL, Kitchin DR, Hedican SP, Nakada SY, Lee FT, Abel EJ. High-powered microwave ablation of t1a renal cell carcinoma: safety and initial clinical evaluation. J. Endourol. 2014 Sep; 28(9):1046-52.
    [PubMed ID: 24846329]
    More Information
  • Best SL, Thapa A, Jackson N, Olweny E, Holzer M, Park S, Wehner E, Zuzak K, Cadeddu JA. Renal oxygenation measurement during partial nephrectomy using hyperspectral imaging may predict acute postoperative renal function. J. Endourol. 2013 Aug; 27(8):1037-40.
    [PubMed ID: 23544949]
    More Information
  • Olweny EO, Faddegon S, Best SL, Jackson N, Wehner EF, Tan YK, Zuzak KJ, Cadeddu JA. Renal oxygenation during robot-assisted laparoscopic partial nephrectomy: characterization using laparoscopic digital light processing hyperspectral imaging. J. Endourol. 2013 Mar; 27(3):265-9.
    [PubMed ID: 22973969]
    More Information
  • Best SL. Editorial comment. Urology 2013 Feb; 81(2):234; discussion 234-5.
    [PubMed ID: 23374765]
    More Information
  • Nakada SY, Best SL. Editorial comment for George et al. J. Endourol. 2013 Jan; 27(1):79.
    [PubMed ID: 23067128]
    More Information


webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System